CAT imposes competition remedy on Genzyme

On 29 September 2005 ,the Competition Appeal Tribunal (CAT) gave its judgment on the remedy to be imposed on Genzyme Limited, following the CAT's earlier decision on the merits of the case (which found that Genzyme had infringed UK competition law in pricing its Cerezyme drug and homecare services for administering Cerezyme).

This case concerns Genzyme's supply of drugs for the treatment of Gaucher's disease. The Office of Fair Trading (OFT) and CAT examined whether it was an abuse of Genzyme's dominance in that market to bundle the supply of Cerezyme with the provision of associated homecare services, and/or to charge independent third party homecare services providers a price for Cerezyme which allowed them no possible margin (a "margin squeeze")